Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
Danielle Nicolazzo,1 Franz Kerdel,1 Francisco Kerdel1,2 1Florida Academic Dermatology Centers, The University of Miami Hospital, Miami, FL, USA; 2Florida International University, Miami, FL, USA Abstract: Psoriasis is a chronic inflammatory disease estimated to affect 1%–3% of the worldwi...
Main Authors: | Nicolazzo D, Kerdel F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-06-01
|
Series: | Psoriasis: Targets and Therapy |
Online Access: | http://www.dovepress.com/critical-appraisal-of-adalimumab-in-the-treatment-of-chronic-plaque-ps-a17342 |
Similar Items
-
Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature
by: Jochen Schmitt, et al.
Published: (2009-06-01) -
Visual Loss Induced by Adalimumab Used for Plaque Psoriasis
by: Norman Saffra, et al.
Published: (2017-03-01) -
Adalimumab for the treatment of psoriasis
by: D Turner, et al.
Published: (2009-09-01) -
A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis
by: Francisco A. Kerdel, et al.
Published: (2019-05-01) -
Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab
by: Chu Y, et al.
Published: (2022-09-01)